Cargando…

SARS-CoV-2 Variants of Concern Delta: a great challenge to prevention and control of COVID-19

Detalles Bibliográficos
Autores principales:	Li, Maochen, Lou, Fuxing, Fan, Huahao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475295/ https://www.ncbi.nlm.nih.gov/pubmed/34580279 http://dx.doi.org/10.1038/s41392-021-00767-1

Ejemplares similares

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency
por: Li, Maochen, et al.
Publicado: (2021)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

Multiple LDLR class A repeats on very‐low‐density lipoprotein receptor promote the cross‐species transmission of Semliki Forest virus
por: Hu, Ruolan, et al.
Publicado: (2023)

The determinants associated with zoonotic potential of influenza A viruses: BTN3A3 evasion mediated by residue mutation in the nucleoprotein
por: Tian, Lili, et al.
Publicado: (2023)

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
por: Noh, Ji Yun, et al.
Publicado: (2021)

The monkeypox outbreak in 2022: adaptive evolution associated with APOBEC3 may account for
por: Chen, Yangzhen, et al.
Publicado: (2022)

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
por: Xu, Ailan, et al.
Publicado: (2022)

Structural insights into the Omicron spike trimer: tackling the challenges of continuously evolving SARS-CoV-2 variants
por: Ou, Junxian, et al.
Publicado: (2022)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Virtual Issue on SARS-CoV-2: Evolution of a Pandemic
por: McGrath, Casey
Publicado: (2023)

SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
por: Zhang, Xiantao, et al.
Publicado: (2022)

The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era
por: Fan, Huahao, et al.
Publicado: (2022)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
por: Wan, Cheng, et al.
Publicado: (2021)

Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern
por: Lyngse, Frederik Plesner, et al.
Publicado: (2022)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Efficient disinfection of SARS-CoV-2-like coronavirus, pseudotyped SARS-CoV-2 and other coronaviruses using cold plasma induces spike protein damage
por: Qin, Hongbo, et al.
Publicado: (2022)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
por: Allison, Susan J.
Publicado: (2020)

A two‐step infection model: From SARS‐CoV‐2 entry and trafficking to egress and spread
por: You, Liting, et al.
Publicado: (2023)

SARS-CoV-2 sensory loss
por: York, Ashley
Publicado: (2022)

Sewer biofilms and SARS-CoV-2
por: Du Toit, Andrea
Publicado: (2023)

SURFing SARS-CoV-2 inhibition
por: Taglialegna, Agustina
Publicado: (2023)

Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants
por: Pawelec, Graham, et al.
Publicado: (2021)

SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
por: Meyerowitz, Eric A., et al.
Publicado: (2022)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022)

Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature
por: Pottage, Thomas, et al.
Publicado: (2023)

Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain
por: Ribes, Marta, et al.
Publicado: (2021)

Level up for culture models - How 3D cell culture models benefit SARS-CoV-2 research
por: Häfner, Sophia Julia
Publicado: (2021)

A CNS gateway for SARS-CoV-2
por: Yates, Darran
Publicado: (2021)

SARS-CoV-2 detected in olfactory neurons
por: Lemprière, Sarah
Publicado: (2021)

Super(antigen) target for SARS-CoV-2
por: Brown, Matthew, et al.
Publicado: (2021)

Cellular basis for SARS-CoV-2 infection
por: Baumann, Kim
Publicado: (2020)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

SARS-CoV-2 nanobodies 2.0
por: Labroussaa, Fabien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tc7ocbunofg4dgc36s26lsf2cg